ATXI (Avenue Therapeutics) FCF Margin %: 0.00% (As of Mar. 2026)


ATXI Avenue Therapeutics Inc ATXI
31 GF Score
Price $0.32
! 1 Warning Sign
View Full Analysis

What is Avenue Therapeutics FCF Margin %?

Avenue Therapeutics ATXI +3.11% 31 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates ATXI with a GF Score™ of 31/100. The stock has 1 warning sign investors should review. Among 959 Biotechnology companies, Avenue Therapeutics ranks better than 50.68% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Avenue Therapeutics's Free Cash Flow for the three months ended in Mar. 2026 was $-0.44 Mil. Avenue Therapeutics's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Avenue Therapeutics's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Avenue Therapeutics's current FCF Yield % is -104.53%.

The historical rank and industry rank for Avenue Therapeutics's FCF Margin % or its related term are showing as below:

ATXI' s FCF Margin % Range Over the Past 10 Years
Min: -130.56   Med: -130.56   Max: -77.28
Current: -77.28

During the past 11 years, the highest FCF Margin % of Avenue Therapeutics was -77.28%. The lowest was -130.56%. And the median was -130.56%.

ATXI's FCF Margin % is ranked better than
50.68% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs ATXI: -77.28

Avenue Therapeutics FCF Margin % Related Terms

Avenue Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Avenue Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Avenue Therapeutics FCF Margin % Chart

Avenue Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -130.56

Avenue Therapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -12.54 0.00 0.00 0.00

ATXI vs PTIX, EVFM, AGTX: FCF Margin % Comparison

For the Biotechnology subindustry, Avenue Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avenue Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avenue Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Avenue Therapeutics's FCF Margin % falls into.


ATXI
31GF Score
Avenue Therapeutics Inc ATXI
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Avenue Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Avenue Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-1.833/1.404
=-130.56 %

Avenue Therapeutics's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.438/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Avenue Therapeutics (ATXI) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avenue Therapeutics and its competitors. According to the industry distribution chart, Avenue Therapeutics ranks #473 out of 959 companies in the Biotechnology industry, placing it in the top 49.3%.
Is Avenue Therapeutics' FCF Margin % too high?
Avenue Therapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Avenue Therapeutics ranks #473 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Avenue Therapeutics has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Avenue Therapeutics' FCF Margin % compare to PTIX and EVFM?
According to the Biotechnology industry distribution chart, Avenue Therapeutics ranks #473 out of 959 companies for FCF Margin %. This puts Avenue Therapeutics in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Avenue Therapeutics and its competitors. Avenue Therapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avenue Therapeutics stock overvalued right now?
Avenue Therapeutics (ATXI) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Avenue Therapeutics' overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Avenue Therapeutics (ATXI), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Avenue Therapeutics Business Description

Address 1111 Kane Concourse, Suite 301, Bay Harbor Islands, FL, USA, 33154
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to overcome limitations of existing treatment options and ultimately transform patient outcomes. Current product candidates include ATX-04, a selective beta adrenergic agonist for Pompe disease, intravenous tramadol (IV tramadol), a Schedule IV opioid for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders. The company operates in one reportable segment, the development and commercialization of therapies for the treatment of neurologic diseases.
31GF Score

Get the complete analysis for ATXI

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.32
Price